<DOC>
	<DOCNO>NCT01286246</DOCNO>
	<brief_summary>Prematurity remain important single factor perinatal morbidity mortality . Unfortunately , rate premature delivery increase Canada especially high Alberta 7.5 % pregnancy end 37 week gestation . Despite year research cause spontaneous preterm labor , effective treatment identify . Progesterone one candidate treatment . The purpose study investigate whether progesterone prolong pregnancy woman symptoms preterm labor . Pregnant woman symptom premature labor invite take part study 22 24 week pregnant . If agree join study , randomly allocate either take progesterone 200mg day via vagina 36 week , take placebo preparation . Neither woman clinician know group . Women baby follow 28 day birth , find length pregnancy , adverse event might occur ( none report previous trial ) , look whether woman take treatment . When study complete , result progesterone group compare placebo group . If progesterone find useful help prolong pregnancy , possible treatment help mother future .</brief_summary>
	<brief_title>Randomized Controlled Trial Vaginal Progesterone Women With Threatened Preterm Labor</brief_title>
	<detailed_description />
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Women symptomatic premature contraction successfully arrest least 12 hour tocolytics . Women symptoms suggestive early preterm labor whose contraction resolve without tocolysis fetal fibronectin positive . Gestational age 23 ( +0 ) 32 ( +6 ) week . Consent take part study . Placenta previa Preterm premature rupture membrane presentation Preexisting hypertension exclude order reduce likelihood iatrogenic preterm delivery within study woman Known major fetal anomaly detect ultrasound Multiple pregnancy Maternal seizure disorder Active history thromboembolic disease Maternal liver disease Known suspect breast malignancy pathology Known suspect progesteronedependent neoplasia Plans move another city pregnancy Previous participation progesterone trial pregnancy Known sensitivity progesterone</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Progesterone</keyword>
	<keyword>Randomized control trial</keyword>
</DOC>